ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Panel Considers Easing Comp Center Independence Requirement, but Realizes It Lacks That Authority

February 18, 1977

In Brief: Fox Chase Joins Temple Health System, Expands Outpatient and Surgical Services

July 6, 2012

In Brief: Weicker Joins Tobacco Company Board; Hatfield To Leave Senate Next Year

December 8, 1995

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011

Murphy Withdraws From SU Position

October 17, 1986

Spartanburg CCOP Makes the List

April 10, 1987